Under construction – not a live service
Sign in
Not yet recruitingNo phase

Tecar Therapy in Chronic Knee Osteoarthritis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 75 years old?

Source: NCT07438392, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Kirsehir Ahi Evran Universitesi
Trial code
NCT07438392
Record updated
2 March 2026
Original description
This study aimed to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.Read full original descriptionShow less

Effects of Tecar Therapy (Targeted Radiofrequency Therapy) on Pain, Physical Function, and Physical Capacity in Patients With Chronic Knee Osteoarthritis: A Randomized Controlled Trial

This study aimed to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.

Inclusion: Patients with Kellgren-Lawrence stage 2 or 3 knee osteoarthritis; Patients with bilateral knee pain for at least 6 weeks; Male and female patients aged 40-75; Patients who accept and sign the informed consent form.

Exclusion: Those who have received physical therapy for knee pain in the last 6 months; Those who have received intraarticular injection treatments such as hyaluronic acid, PRP, or steroids for knee pain in the last 6 months; Those who have undergone knee surgery for any reason; Those with existing neurological, cognitive, or psychiatric disorders; Those with a history of malignancy; Those with local vascular or sensory impairment; Those with local or systemic infections; Those with inflammatory arthritis; Those with pacemakers; Those with open wounds on the skin; Pregnant or breastfeeding.

ClinicalTrials.gov NCT07438392